Related Experiment Video
Updated: May 27, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Estimation of total mediation effect for a binary trait in a case-control study for high-dimensional omics mediators†
Zhiyu Kang1, Li Chen2, Peng Wei3
1Division of Biostatistics and Health Data Science, University of Minnesota, MN 55455.
Abstract:
Mediation analysis helps uncover how exposures impact outcomes through intermediate variables. Traditional mean-based total mediation effect measures can suffer from the cancellation of opposite component-wise effects and existing methods often lack the power to capture weak effects in high-dimensional mediators. Additionally, most existing work has focused on continuous outcomes, with limited attention to binary outcomes, particularly in case-control studies. To fill in this gap, we propose an total mediation effect measure under the liability framework, providing a causal interpretation and applicable to various high-dimensional mediation models. We develop a cross-fitted, modified Haseman-Elston regression-based estimation procedure tailored for mediation analysis in case-control studies, which can also be applied to cohort studies. Our estimator remains consistent in the presence of non-mediators and weak effect sizes in extensive simulations. Theoretical justification on consistency is provided under mild conditions and without requiring exact mediator selection. In a case-control substudy of the Women's Health Initiative involving 2150 individuals, we found that many metabolites were mediators with weak effects in the path from BMI to coronary heart disease, and an estimated 89% (95% CI: 73%-91%) of the variation explained by BMI in the underlying liability of coronary heart disease was estimated to be mediated by the measured metabolomics. The proposed estimation procedure is implemented in R package "r2MedCausal", available on GitHub.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
08:27Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Chi-square Analysis
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
Polygenic Traits
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Odds Ratio
Mechanistic Models: Compartment Models in Individual and Population Analysis